First ‘pathoconnectome’ could point toward new treatments for neurodegenerative diseases — ScienceDaily
Scientists from the John A. Moran Eye Center at the University of Utah have achieved another first in the field...
Neurodegenerative
Biomarker for earlier diagnosis of neurodegenerative diseases detected in the eye
Reviewed by Emily Henderson, B.Sc.Sep 21 2020 A new study led by Boston Medical Center researchers indicates a well-known biomarker...
How the brain’s immune cells could guide treatment of neurodegenerative diseases
Human behavior relies on the excitation and inhibition of neurons, and scientists have long believed that neurons themselves are largely...
Finding New Drugs for Alzheimer’s and Other Neurodegenerative Diseases
Effective therapies for neurodegenerative diseases like Alzheimer’s are urgently needed. But developing new drugs is difficult, time-consuming, and expensive, with...
First ‘pathoconnectome’ could point toward new treatments for neurodegenerative diseases
IMAGE: A 2-D pathoconnectome image shows rod bipolar cell dendrites and their synapse locations with rod (red), cone (blue), and indeterminate...
Unlocking the mystery of tau for treatment of neurodegenerative diseases
Under normal physiological conditions, FUS and SFPQ interact in the nucleus of nerve cells and regulate the alternative splicing of...
How shape-memory polymers may advance treatment of neurodegenerative d
Flexible displays, electronics and even batteries are currently being tested and will be part of our daily lives in a...
Market Failure? kENUP and YUVEDO High-Level Online Event Kick-starts Call for Projects Tackling the Growing Threat of Parkinson’s and Other Neurodegenerative Diseases.
BERLIN--(BUSINESS WIRE)--On Friday, 18 September 2020, YUVEDO Foundation and kENUP Foundation held a high-level online conference to kick-start an open...
Libra launches with a $29M series A to treat neurodegenerative diseases | 2020-09-23
In the past 10 years, the advances in understanding the etiology of neurodegenerative diseases have been dramatic. “The development of...
Faulty transportation of messenger RNA is the culprit in neurodegenerative diseases
Fig.1 Ribosomal protein mRNA partially reversed impaired axonal outgrowth found in TDP-43-knockdown neurons. Decrease of TDP-43 in mouse cortical neurons...
Libra Therapeutics Launches with $29 Million Series A to Develop Novel Therapeutics for Neurodegenerative Diseases
SAN DIEGO--(BUSINESS WIRE)--Sep 23, 2020-- Libra Therapeutics, Inc. launched today to develop novel drug candidates focused on restoring the cellular...
